Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,807,278
New position
Shares Held
7,182
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#2,043
of 4,153 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NBH Bank holds $11,297,151 across 11 Drug Manufacturers - General names. ABBV ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,892 | $4,668,181 | |
| 2 | JNJ |
Johnson & Johnson
|
11,346 | $2,881,543 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
7,182 | $1,807,278 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,243 | $1,316,225 | |
| 5 | PFE |
Pfizer Inc
|
15,555 | $374,564 | |
| 6 | AMGN |
Amgen Inc
|
308 | $111,532 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,340 | $77,210 | |
| 8 | NVS |
Novartis AG
|
231 | $36,202 |
All Filings in ABBV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,807,278 | 7,182 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||